Intrauterine adhesion (IUA) is a common gynaecological disease that develops from
infection or trauma. IUA disease may seriously affect the physical and mental health of …

Progressive loss of physiological integrity and accumulation of degenerative changes
leading to functional impairment and increased susceptibility to diseases are the main …

Background The global delay in women's reproductive age has raised concerns about age-
related infertility. The decline in oocyte quality is a limiting factor of female fertility, yet there …

BACKGROUND The positive effects of growth hormone (GH) on IVF are often attributed to
improvements in oocyte and embryo quality. While emerging evidence emphasizes GH …

Growth hormone (GH) is a polypeptide hormone that could reduce the mitochondria-
mediated oxidative stress and improve the mitochondrial function. However, the …

Growth hormone (GH) has been used as a co-gonadotrophin in assisted reproduction,
particularly in poor ovarian responders. The application of GH has been alleged to activate …

Oocyte quality typically begins to decline with aging, which contributes to subfertility and
infertility. However, there is still no effective treatment to restore the ovarian reserve and …

Background Increasing evidence supports that the co-treatment with growth hormone (GH)
enhances ovarian response and oocyte quality during controlled ovarian stimulation (COS) …

Treatment with antioxidants is increasingly used to slow down aging processes in different
organs of the human body, including those implicated in female fertility. There is a plethora …

Purpose Growth hormone (GH) supplementation in association with in vitro fertilization (IVF)
is worldwide again increasing, even though study outcomes have been discrepant. Since …